"id:ID","uri","objective_desc"
"1623","http://id.d4k.dk/dataset/study/1/OBJ001","To assess the safety of AZD6738 and Durvalumab combination or AZD6738 and Olaparib combination in biliary tract cancer patients"
"1624","http://id.d4k.dk/dataset/study/1/OBJ002","To assess the effect of AZD6738 and Durvalumab combination or AZD6738 and Olaparib combination in biliary tract cancer patients who have failed to 1st-line chemotherapy and are in second phase of disease"
"1625","http://id.d4k.dk/dataset/study/1/OBJ003","To assess the effect of AZD6738 and Durvalumab combination or AZD6738 and Olaparib combination in biliary tract cancer patients who have failed to 1st-line chemotherapy"
